Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ACRS Aclaris Therapeutics

Watchlist
14.080
+0.350+2.55%
Close  02/07 16:00 ET
14.0800.0000.00%
Post Mkt Price 02/07 16:01 ET
High
14.160
Open
13.910
Turnover
12.96M
Low
13.610
Pre Close
13.730
Volume
931.86K
Market Cap
938.90M
P/E(TTM)
Loss
52wk High
18.958
Shares
66.68M
P/E(Static)
Loss
52wk Low
9.840
Float Cap
616.35M
Bid/Ask %
0.00%
Historical High
33.880
Shs Float
43.78M
Volume Ratio
0.76
Historical Low
0.700
Dividend TTM
--
Div Yield TTM
--
P/B
4.27
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.13%
Amplitude
4.01%
Avg Price
13.911
Lot Size
1
Float Cap
616.35M
Bid/Ask %
0.00%
Historical High
33.880
Shs Float
43.78M
Volume Ratio
0.76
Historical Low
0.700
Dividend TTM
--
P/B
4.27
Dividend LFY
--
Turnover Ratio
2.13%
Amplitude
4.01%
Avg Price
13.911
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
CEO: Mr. Douglas J. Manion
Market: NASDAQ
Listing Date: 10/07/2015
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist